The Cancer Consortium

Cancer News & Information Center

Friday, October 30th, 2026

Menu

  • Home
  • Members
    • Travera
    • Soligenix (SNGX)
    • NuView Life Sciences
  • News
    • MEMBER NEWS
    • FINDINGS
    • INDUSTRY
  • INTERVIEWS
    • CEOs
    • KOLs
  • Cancer Types
    • Breast Cancer
    • Cervical Cancer
    • Head and Neck Cancer
  • Database
  • About
    • Altru Cancer
    • Cancer Consortium
    • Newsletter
    • Research
  • RESOURCES
    • Foundations
    • Patient Resources
    • Media Resources

ITUS’ Blood Test Detects Early Forms of Solid Tumor Based Cancers

By Alexandra Barnes on March 11, 2017

ITUS Corporation is an early cancer detection technology company currently developing a platform called Cchek, a series of inexpensive, non-invasive blood tests for the early detection of cancer. Specifically, the test will […]

Dr. Christopher Schaber – President and CEO of Soligenix

By Alexandra Barnes on March 11, 2017

  Dr. Christopher Schaber is the President and CEO of Soligenix, a late stage biopharmaceutical company with a pipeline of pharmaceutical products to treat a variety of rare diseases with an unmet […]

BIO-CEO Wraps Up 19th Annual Investor Conference

By Global Cancer Consortium on February 18, 2017 • ( Leave a comment )

Now in its 19th year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. With a mission to support industry-wide […]

Angionetics Gene Therapy Candidate Selected for FDA Fast Track Program

By Alexandra Barnes on February 14, 2017

Angionetics Inc. reported that the FDA has granted Fast Track designation for the Phase III clinical investigation of Generx (Ad5FGF-4) cardiovascular angiogenic gene therapy. Angionetics is a biotechnology company focused on the clinical and […]

CytRx Corporation’s Treatment for Small Cell Lung Cancer

By Alexandra Barnes on February 13, 2017

CytRx Corporation is a clinical-stage, biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer. CytRx’s initial focus is on seeking regulatory approval for and commercialization of it’s […]

Promaxo Receives $200k TEDCO Investment

By Alexandra Barnes on January 28, 2017

The Maryland Technology Development Corporation (TEDCO) announced that two companies received $400,000 in funding through its Life Science Investment Fund (LSIF) – one of TEDCO’s Seed Investment Funds. TEDCO is the go-to source for entrepreneurial […]

BODYQuant’s Early Disease Detection Through Organ and Tissue Measurements

By Alexandra Barnes on January 26, 2017

Numerous global public and private initiatives are underway offering exceptional opportunity to revolutionize healthcare delivery. More advanced diagnostic techniques, based on individual patient characteristics including biomarker identification, evidence-based medicine, and a quality over […]

Guided Therapeutics Enters into LuViva® Advanced Cervical Scan Agreement for China

By Alexandra Barnes on January 26, 2017

Guided Therapeutics, the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has reached an agreement with Shandong Yaohua Medical Instrument Corporation in […]

Posts navigation

‹ Newer 1 … 23 24 25 26 27 28 29 30 31 32 33 … 84 Older ›

INTERVIEWS »

INTERVIEW: Travera CEO Clifford Reid PhD

INTERVIEW: Soligenix CEO Christopher Schaber PhD.

INTERVIEW: Biden Cancer Initiative’s Greg Simon

PROFILES »

Gray Scale Images Convert to Detailed Color Images to Better Diagnose Breast Cancer

New Technology Using Light Therapy Kills Cells with No Side Effects

Real-time, In vivo Imaging Platform to Guide Surgeon During Cancer Surgery

Image result for cancer commons

Cancer Progress Report

Altru Cancer Progress Report June 2019

Subscribe to Cancer Progress Report

 

 

About Cancer Consortium

Members of the Global Cancer Consortium believe that progress occurs through collaboration which can occur through improved information.

This news site aggregates information and profiles of the member companies and organizations.

Its Cancer Progress Report reaches thousands of investors and industry professionals.

Global Cancer Consortium

The Cancer Consortium was formed by the Altru Cancer Project to offer one place to learn about the most promising developments, technologies and companies focused on Cancer.

 

 

  • Top categories: COMPANIES / cancer / Blog / feature2 / NEWS / Featured Articles / MEMBER NEWS / feature1 / Uncategorized / Member Spotlight
  • Top tags: cancer / breast cancer / diagnostics / oncology / prostate cancer / clarient / peter winter / brain cancer / melanoma / immunotherapy
Proudly powered by WordPress | Theme: Broadsheet by Pro Theme Design.